Objective Blockade of the checkpoint inhibitor programmed death 1 ligand(PD-L1)has demonstrated remarkable success in the clinic for the treatment of cancer; however,a majority of tumors are progressi
Objective The radiation resistance of lung adenocarcinoma remains a major therapeutic problem,and chemotherapy drugs are often used to carry out the follow-up treatment.Pemetrexed is an important chem
Objective Pancreatic ductal adenocarcinoma(PDAC)is an aggressive malignancy and is predicted to be the second leading cause of cancer-related mortality in the next decades.
Objective Burkitt lymphoma(BL)is a highly aggressive but potentially curable type of B-cell non-Hodgkin lymphoma(NHL)with a cellular doubling time of 24–48 hours.Derived from B-cell germinal centers,B
Objective Lung cancer has been the leading cause of cancer death,among which approximately 80%is non-small cell lung cancer(NSCLC),besides,NSCLC patients with brain metastases had a poor prognosis.Mor